OR Royalties Inc. (OR) to Issue Quarterly Dividend of $0.07 on October 15th

OR Royalties Inc. (NYSE:ORGet Free Report) announced a quarterly dividend on Wednesday, August 5th. Stockholders of record on Wednesday, September 30th will be paid a dividend of 0.065 per share by the basic materials company on Thursday, October 15th. This represents a c) annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Wednesday, September 30th.

OR Royalties has raised its dividend payment by an average of 0.1%per year over the last three years and has increased its dividend annually for the last 1 consecutive years. OR Royalties has a dividend payout ratio of 33.3% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect OR Royalties to earn $1.26 per share next year, which means the company should continue to be able to cover its $0.25 annual dividend with an expected future payout ratio of 19.8%.

OR Royalties Trading Down 0.1%

OR opened at $32.20 on Friday. The stock’s 50 day simple moving average is $31.78 and its 200-day simple moving average is $37.29. The stock has a market cap of $6.03 billion, a PE ratio of 21.46 and a beta of 0.75. OR Royalties has a 1 year low of $27.54 and a 1 year high of $48.06.

OR Royalties (NYSE:ORGet Free Report) last issued its earnings results on Wednesday, August 5th. The basic materials company reported $0.32 EPS for the quarter, topping the consensus estimate of $0.31 by $0.01. OR Royalties had a return on equity of 16.56% and a net margin of 78.04%.The firm had revenue of $97.82 million during the quarter, compared to analysts’ expectations of $97.93 million. Equities analysts forecast that OR Royalties will post 1.27 earnings per share for the current fiscal year.

About OR Royalties

(Get Free Report)

OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.

The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.

Featured Articles

Dividend History for OR Royalties (NYSE:OR)

Receive News & Ratings for OR Royalties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OR Royalties and related companies with MarketBeat.com's FREE daily email newsletter.